Evidence of insufficient quality of reporting in patent landscapes in the life sciences
Nat Biotechnol
.
2017 Mar 7;35(3):210-214.
doi: 10.1038/nbt.3809.
Authors
James A Smith
1
2
,
Zeeshaan Arshad
2
3
,
Hannah Thomas
3
,
Andrew J Carr
1
,
David A Brindley
2
4
Affiliations
1
Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
2
The Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation, University of Oxford, Oxford, UK.
3
School of Medicine, University of St. Andrews, St. Andrews, UK.
4
Department of Paediatrics, University of Oxford, Oxford, UK.
PMID:
28267720
DOI:
10.1038/nbt.3809
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Biological Science Disciplines / legislation & jurisprudence*
Humans
Patents as Topic / legislation & jurisprudence*
Grants and funding
MC_PC_12020/MRC_/Medical Research Council/United Kingdom
MC_PC_14103/MRC_/Medical Research Council/United Kingdom